{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:57:24Z","timestamp":1790456244524,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&amp;S Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.xfre.2024.12.003","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T16:42:18Z","timestamp":1734799338000},"page":"4-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of dramatic weight loss with the new injectable medications on reproduction in healthy non\u2013polycystic ovary syndrome obese women"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7952-1428","authenticated-orcid":false,"given":"Zaher","family":"Merhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2024.12.003_bib2","first-page":"1515","article-title":"US obesity prevalence surged over the past decade","volume":"330","author":"Harris","year":"2023","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.xfre.2024.12.003_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50934","article-title":"Obesity, twin pregnancy, and the role of assisted reproductive technology","volume":"7","author":"Bone","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.xfre.2024.12.003_bib4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.fertnstert.2009.06.046","article-title":"Impact of bariatric surgery on female reproduction","volume":"92","author":"Merhi","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2024.12.003_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.fertnstert.2006.07.1499","article-title":"Weight loss by bariatric surgery and subsequent fertility","volume":"87","author":"Merhi","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2024.12.003_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.soard.2021.09.008","article-title":"Effects of bariatric surgery on the menstruation- and reproductive-related hormones of women with obesity without polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lv","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.xfre.2024.12.003_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2352-4642(23)00033-0","article-title":"Semaglutide and social media: implications for young women with polycystic ovarian syndrome","volume":"7","author":"Keating","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.xfre.2024.12.003_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2017.11.004","article-title":"Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells","volume":"178","author":"Nishiyama","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.xfre.2024.12.003_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfre.2024.12.003_bib10","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2024.12.003_bib11","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2024.12.003_bib12","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.3390\/jcm12185915","article-title":"Do GLP-1 analogs have a place in the treatment of PCOS? New insights and promising therapies","volume":"12","author":"Szczesnowicz","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xfre.2024.12.003_bib13","doi-asserted-by":"crossref","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","article-title":"Obesity, polycystic ovary syndrome, and infertility: A New Avenue for GLP-1 receptor agonists","volume":"105","author":"Cena","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.xfre.2024.12.003_bib14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/humupd\/dmz019","article-title":"The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective","volume":"25","author":"Jensterle","year":"2019","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfre.2024.12.003_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-18-0175","article-title":"Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study","volume":"179","author":"Salamun","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.xfre.2024.12.003_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1484321","article-title":"GLP-1\/GLP-1R signaling regulates ovarian PCOS-associated granulosa cells proliferation and antiapoptosis by modification of Forkhead box protein O1 phosphorylation sites","volume":"2020","author":"Sun","year":"2020","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.xfre.2024.12.003_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.repbio.2019.07.003","article-title":"Liraglutide treatment effects on rat ovarian and uterine tissues","volume":"19","author":"Saber","year":"2019","journal-title":"Reprod Biol"},{"key":"10.1016\/j.xfre.2024.12.003_bib18","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1210\/en.2014-1978","article-title":"GLP-1 increases preovulatory LH source and the number of mature follicles, as well as synchronizing the onset of puberty in female rats","volume":"156","author":"Outeiri\u00f1o-Iglesias","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.xfre.2024.12.003_bib19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/ph16070964","article-title":"Dulaglutide ameliorates intrauterine adhesion by suppressing inflammation and epithelial-mesenchymal transition via inhibiting the TGF-\u03b2\/Smad2 signaling pathway","volume":"16","author":"Wang","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.xfre.2024.12.003_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170481","article-title":"The glucagon-like peptide-1 (GLP-1) analog exenatide ameliorates intrauterine adhesions in mice","volume":"137","author":"Ma","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.xfre.2024.12.003_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rbmo.2017.03.023","article-title":"Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial","volume":"35","author":"Nylander","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfre.2024.12.003_bib22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuropharm.2009.06.015","article-title":"Age-related LH surge dysfunction correlates with reduced responsiveness of hypothalamic anteroventral periventricular nucleus kisspeptin neurons to estradiol positive feedback in middle-aged rats","volume":"58","author":"Lederman","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xfre.2024.12.003_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1871525716666180118152158","article-title":"Coagonist of GLP-1 and glucagon receptor ameliorates development of non-alcoholic fatty liver disease","volume":"16","author":"Patel","year":"2018","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.xfre.2024.12.003_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/08977194.2015.1125349","article-title":"Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice","volume":"33","author":"Sancar-Bas","year":"2015","journal-title":"Growth Factors"},{"key":"10.1016\/j.xfre.2024.12.003_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.peptides.2017.12.007","article-title":"Exendin-4 partly ameliorates - hyperglycemia-mediated tissue damage in lungs of streptozotocin-induced diabetic mice","volume":"99","author":"Oztay","year":"2018","journal-title":"Peptides"}],"container-title":["F&amp;S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334124001466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334124001466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T21:54:29Z","timestamp":1742334869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666334124001466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2666334124001466"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2024.12.003","relation":{},"ISSN":["2666-3341"],"issn-type":[{"value":"2666-3341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of dramatic weight loss with the new injectable medications on reproduction in healthy non\u2013polycystic ovary syndrome obese women","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}